Photoactivatable crosslinker

ABSTRACT

Described herein is a degradable linking agent of formula Photo 1 -LG-Photo 2 , wherein Photo 1  and Photo 2  independently represent at least one photoreactive group and LG represents a linking group comprising one or more silicon atoms or one or more phosphorous atoms. The degradable linking agent includes a covalent linkage between at least one photoreactive group and the linking group, wherein the covalent linkage between at least one photoreactive group and the linking group is interrupted by at least one heteroatom. A method for coating a support surface with the degradable linking agent, coated support surfaces and medical devices are also described.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation application of U.S. Pat. No.8,889,760, filed Mar. 29, 2011, which claims the benefit of U.S.Provisional Application No. 61/319,127, filed Mar. 30, 2010, thecontents of which are herein incorporated by reference.

TECHNICAL FIELD

The present invention relates to a linking agent having one or morephotoactivatable groups. In particular, the invention provides adegradable linking agent.

BACKGROUND OF THE INVENTION

Photochemically reactive functional groups (“photoreactive groups”) arefunctional groups that, when exposed to an appropriate energy source,undergo a transformation from an inactive state (i.e., ground state) toa reactive intermediate capable of forming covalent bonds withappropriate materials. Photoreactive groups can be used, for instance,to derivatize a target molecule (e.g., thermochemically), in order tothen photochemically attach the derivatized target molecule to asurface. Photoreactive groups can also be used as photoinitiators forpolymerization reactions.

SUMMARY OF THE INVENTION

Disclosed herein is a degradable linking agent having formulaPhoto¹-LG-Photo², wherein Photo¹ and Photo², independently, represent atleast one photoreactive group and LG represents a linking group. In oneembodiment, one or more photoreactive groups include an aryl ketone. Ina more particular embodiment, one or more photoreactive groups includebenzophenone.

In one embodiment, the linking group includes one or more silicon atomsor one or more phosphorus atoms, wherein each photoreactive group isindependently bound to the linking group by a covalent linkage thatincludes at least one heteroatom. In one embodiment, at least oneheteroatom is selected from oxygen, nitrogen, selenium, sulfur, or acombination thereof. In one embodiment, at least one photoreactivegroup, heteroatom and linking group form an ether or an amine.

In a more particular embodiment, the linking group includes one siliconatom covalently bound to at least two photoreactive groups. In anotherembodiment, the linking group includes at least two silicon atoms. Inanother embodiment, the linking group has the formula Si—Y—Si, wherein Yrepresents a linker that can be null, an amine, ether, linear orbranched C₁-C₁₀ alkyl, or a combination thereof. In one embodiment, Y isselected from O, CH₂, OCH₂CH₂O and O(CH₂CH₂O)_(n), wherein n is aninteger between 1 and 5, between 1 and 10, between 1 and 15, between 1and 20, between 1 and 25, or between 1 and 30.

In another embodiment, the linking group includes one or morephosphorester bonds and/or one or more phosphoramide bonds wherein oneor more phosphorester and/or one or more phosphoramide bonds form acovalent bond with at least one photoreactive group, such that thelinking group includes at least two photoreactive groups. In oneembodiment, the linking group is covalently attached to threephotoreactive groups, wherein each photoreactive group is covalentlybound to the linking group by a phosphorester or phosphoramide bond. Inanother embodiment, the linking group includes at least one phosphorusatom with a phosphorus-oxygen double bond (P═O), wherein at least onephotoreactive group is bound to at least one phosphorus atom. In yetanother embodiment, the linking group includes one phosphorus atom witha phosphorus-oxygen double bond (P═O), wherein at least two or threephotoreactive groups are covalently bound to the phosphorus atom. Inanother embodiment, the linking group includes at least two phosphorusatoms, wherein at least one phosphorus atom includes a phosphorus-oxygendouble bond (P═O), and at least one or at least two photoreactive groupsare covalently bound to each phosphorus atom.

According to one embodiment, the degradable linking agent is capable of,upon activation of one or more photoreactive groups, covalent attachmentto a surface, target molecule, or a combination thereof. Also providedis a method of coating a support surface with a linking agent in orderto provide the surface with latent reactive groups. In one embodiment,the method includes steps of: providing a support surface; applying tothe support surface the degradable linking agent; and illuminating thelinking agent upon the support surface under conditions suitable toactivate a first photoreactive group to attach the linking agent to thesurface, wherein a second photoreactive species remains unbound to thesupport surface and is able to revert to a latent reactive state. Asupport surface bearing a coating that includes a polymer layer attachedto the surface by a degradable linking agent is also provided, in whicha first photoreactive group of the linking agent, when activated in thepresence of the support surface, is able to attach the linking agent tothe support surface, and a second photoreactive group of the linkingagent, when activated in the presence of a coating agent, is able toattach the coating the surface. Also described herein is a combinationthat includes a medical device and a polymeric coating, wherein thecoating is attached to the medical device by a degradable linking agent.

This summary is an overview of some of the teachings of the presentapplication and is not intended to be an exclusive or exhaustivetreatment of the present subject matter. Further details are found inthe detailed description and appended claims. Other aspects will beapparent to persons skilled in the art upon reading and understandingthe following detailed description and viewing the drawings that form apart thereof, each of which is not to be taken in a limiting sense. Thescope of the present invention is defined by the appended claims andtheir legal equivalents.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 shows a reaction pathway for the generation of a degradablelinking agent as described herein.

FIG. 2 shows a reaction pathway for the generation of a degradablelinking agent as described herein.

FIG. 3 shows a reaction pathway for the generation of a degradablelinking agent as described herein.

FIG. 4 shows a reaction pathway for the generation of a degradablelinking agent as described herein.

FIG. 5 shows a reaction pathway for the generation of a degradablelinking agent as described herein.

FIG. 6 shows a reaction pathway for the generation of a degradablelinking agent as described herein.

FIG. 7 shows a reaction pathway for the generation of a degradablelinking agent as described herein.

FIG. 8 shows a reaction pathway for the generation of a degradablelinking agent as described herein.

While the invention is susceptible to various modifications andalternative forms, specifics thereof have been shown by way of exampleand drawings, and will be described in detail. It should be understood,however, that the invention is not limited to the particular embodimentsdescribed. On the contrary, the intention is to cover all modifications,equivalents, and alternatives falling within the spirit and scope of theinvention.

DETAILED DESCRIPTION

Described herein is a degradable linking agent. The degradable linkingagent includes one or more photoreactive groups and a linking group,wherein each photoreactive group is independently attached to thelinking group by a degradable linkage. In other embodiments, thedegradable linking agent includes two or more photoreactive groups. Instill other embodiments, the degradable linking agent includes three ormore photoreactive groups. In one embodiment, the linking agent iscapable of, upon activation of one or more photoreactive groups,covalent attachment to a surface, target molecule, or a combinationthereof. In particular, each photoreactive group of the linking agentmay be capable of being activated to form a covalent bond with thesurface or target molecule.

The linking agent described herein is particularly useful forapplications in which it is desirable to have a linking agent that candegrade over time. For example, in some instances, it may be desirableto have a surface coating on an implanted device with one propertyinitially and a different property over time. In such a case, thedegradable linking agent can be use to apply a coating on the implanteddevice that degrades over time to expose a surface or base coat with oneor more different properties. In one embodiment, the linking agent isused to attach a hydrophobic coating to a surface. In anotherembodiment, the linking agent is used to attach a hydrophilic coating toa surface. In yet another embodiment, the degradable linking agent isused to apply a hydrophilic coating on an implantable medical devicethat will degrade over time to expose a hydrophobic surface or basecoat, or vice versa.

In some instances, it may be desirable to include one or more bioactiveagents in a surface coating. In one embodiment, the linking agent can beused for delivery of one or more bioactive agents. For example, thelinking agent may be suitable for use in combination with a drugdelivery coating, in particular for use in connection with bioactiveagents that can tolerate (e.g., remain effective) exposure toultra-violet radiation.

In one embodiment, one or more photoreactive groups of the linking agentcan be used as an initiator for photopolymerization. In one embodiment,the linking agent is used in connection with a composition that iscapable of in situ polymerization. In one embodiment, the linking agentcan be used in connection with a biocompatible, biodegradable polymerfoam. In one embodiment, the linking agent is used in connection with abiodegradable foam used for the treatment of wounds, such as deep orcavernous wounds. For example, the linking agent can be used inconnection with a biocompatible foam formed using biocompatible monomersor macromers in combination with a polymerization initiator and gasgeneration components.

In another embodiment, the linking agent can be used in the generationof degradable grafts for tissue engineering. For example, the linkingagent can be used to generate a degradable three dimensional structure,sometimes referred to as a polymeric scaffolding or extracellularmatrix, for cell attachment and migration. The polymeric scaffolding canbe used in connection with tissue engineering technology for the repairand/or replacement of portions of or entire tissues and/or organs (e.g.,bone, cartilage, blood vessels, bladder, etc.). In addition to providinga scaffolding with a desired porosity and pore size to facilitate cellseeding and diffusion of both cells and nutrients, the linking agent isbiodegradable. Biodegradability is often an important factor in thedevelopment of tissue scaffolding, so that the graft can be absorbed bythe surrounding tissues and the need for surgical removal can beavoided.

Degradable Linking Agent

As discussed above, the degradable linking agent includes one or morephotoreactive groups attached to a linking group. The degradable linkingagent can be represented by the formula Photo¹-LG-Photo², wherein Photo¹and Photo² independently represent at least one photoreactive group andLG represents a linking group. The term “linking group” as used herein,refers to a segment or group of molecules configured to connect two ormore molecule to each another, wherein the linking group is capable ofdegrading under one or more conditions. In one embodiment, the linkinggroup includes at least one silicon atom. In another embodiment, thelinking group includes at least one phosphorus atom.

The term “degradable linking group” as used herein, refers to a moietyconfigured to connect one molecule to another, wherein the linking groupis capable of cleavage under one or more conditions. The term“biodegradable” as used herein, refers to degradation in a biologicalsystem, and includes for example, enzymatic degradation or hydrolysis.It should be noted that the term “degradable” as used herein includesboth enzymatic and non-enzymatic (or chemical) degradation. It is alsounderstood that hydrolysis can occur in the presence of or without anacid or base. In one embodiment, the linking agent is water soluble. Inanother embodiment, the linking agent is not water soluble.

In addition to providing a degradable bond, the linking group canfunction as a spacer, for example, to increase the distance between thephotoreactive groups of the linking agent. For example, in someinstances it may be desirable to provide a spacer to reduce sterichindrance that may result between the photoreactive groups, which couldinterfere with the ability of the photoreactive groups to form covalentbonds with a support surface, or from serving as a photoinitiator forpolymerization. As described herein, it is possible to vary the distancebetween the photoreactive groups, for example, by increasing ordecreasing the spacing between one or more photoreactive groups.

As described herein, one or more photoreactive groups can be bound to alinking group by a degradable linkage. In one embodiment, the degradablelinkage between the photoreactive group and the linking group includesat least one heteroatom, including, but not limited to oxygen, nitrogen,selenium, sulfur or a combination thereof. In one embodiment, aphotoreactive group, linking group and heteroatom form an ether(R¹—O—R²), wherein R¹ is a photoreactive group and R² is a linkinggroup. In another embodiment, a photoreactive group, linking group andheteroatom form an amine,

wherein R¹ is a photoreactive group, R² is a linking group, and R³ ishydrogen, aryl or alkyl, a photoreactive group, or a hydroxyl or saltthereof. In one embodiment, R³ is cyclic, linear or branched, saturatedor unsaturated, aromatic or heteroaromatic, or a combination thereof.The stability of the ether and/or amine linkage can be influenceddepending upon the size (e.g., chain length, branching, bulk, etc.) ofthe substituents. For example, bulkier substituents will generallyresult in a more stable linkage (i.e., a linking agent that is slower todegrade in the presence of water and/or acid).

In one embodiment, the linking group includes one or more silicon atoms.In a particular embodiment, the linking group includes one silicon atom(which can be referred to as a monosilane) covalently bound to at leasttwo photoreactive groups. In another embodiment, the linking groupincludes at least two silicon atoms (which can be referred to as adisilane). In one embodiment, the linking group can be represented bythe formula Si—Y—Si, wherein Y represents a linker that can be null(e.g., the linking group includes a direct Si—Si bond), an amine, ether,linear or branched C₁-C₁₀ alkyl, or a combination thereof. In oneembodiment, Y is selected from O, CH₂, OCH₂CH₂O and O(CH₂CH₂O)_(n),wherein n is an integer between 1 and 5, between 1 and 10, between 1 and15, between 1 and 20, between 1 and 25, or between 1 and 30. Oneembodiment of a disilane linking agent is shown below

wherein R¹, R², R⁸ and R⁹ can be any substitution, including, but notlimited to H, alkyl, halide, hydroxyl, amine, or a combination thereof;R³, R⁴, R⁶ and R⁷ can be alkyl, aryl or a combination thereof; R⁵ can beany substitution, including but not limited to O, alkyl or a combinationthereof; and each X, independently, can be O, N, Se, S, or alkyl, or acombination thereof. One specific embodiment is shown below:

In one embodiment, the degradable linking agent can be represented bythe formula

wherein Photo¹ and Photo², independently, represent one or morephotoreactive groups and n is an integer between 1 and 10, wherein thedegradable linking agent comprises a covalent linkage between at leastone photoreactive group and the linking group, wherein the covalentlinkage between at least one photoreactive group and the linking groupis interrupted by at least one heteroatom. In general, a longerhydrocarbon chain between the two silicon atoms will tend to increasethe flexibility of the linking agent and may facilitate crosslinkingbetween a greater number of polymers than a linking agent with a shortercarbon chain, since the photoreactive groups can react with polymerslocated farther apart from one another. In the formula shown above, R¹,R², R³, R⁴ are independently alkyl or aryl, including, but not limitedto cyclic, linear or branched, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof. In a more particularembodiment, R¹-R⁴ are independently phenyl, methyl, ethyl, isopropyl,t-butyl, or a combination thereof. In another embodiment, R¹-R⁴ can alsobe, independently, a photoreactive group. In yet another embodiment,R¹-R⁴ can also be, independently, hydroxyl or salt thereof. In oneembodiment, the hydroxyl salt includes a counterion that is lithium,sodium, potassium, or a combination thereof.

In another embodiment, the linking agent can be represented by theformula

wherein Photo¹ and Photo², independently, represent one or morephotoreactive group, wherein the degradable linking agent comprises acovalent linkage between at least one photoreactive group and thelinking group, wherein the covalent linkage between at least onephotoreactive group and the linking group is interrupted by at least oneheteroatom; R¹ and R² are independently alkyl or aryl, including, butnot limited to cyclic, linear or branched, saturated or unsaturated,aromatic or heteroaromatic, or a combination thereof. In a moreparticular embodiment, R¹ and R² are independently phenyl, methyl,ethyl, isopropyl, t-butyl, or a combination thereof. R¹ and R² can alsobe, independently, a photoreactive group, wherein the degradable linkingagent comprises a covalent linkage between at least one photoreactivegroup and the linking group, wherein the covalent linkage between atleast one photoreactive group and the linking group is interrupted by atleast one heteroatom; or hydroxyl or salt thereof. In one embodiment,the hydroxyl salt includes a counterion that is lithium, sodium,potassium, or a combination thereof. One embodiment of a monosilanelinking agent is shown below

in which R¹ and R⁵ can be any substitution, including, but not limitedto H, halogen, amine, hydroxyl, alkyl, or a combination thereof; R² andR⁴ can be any substitution, except OH, including, but not limited to H,alkyl or a combination thereof; R³ can be alkyl, aryl or a combinationthereof, including, for example, methyl, ethyl, propyl, isopropyl andbutyl; and X, independently, can be O, N, Se, S, alkyl or a combinationthereof.

In another embodiment, the linking group includes one or morephosphorous atoms. In one embodiment, the linking group includes onephosphorus atom (which can also be referred to as a mono-phosphoruslinking group). In another embodiment, the linking agent includes twophosphorus atoms (which can also be referred to as a bis-phosphoruslinking group). In one embodiment, the linking group comprises at leastone phosphorus atom with a phosphorus-oxygen double bond (P═O), whereinat least one or two photoreactive groups are bound to the phosphorusatom. In another embodiment, the linking group comprises one phosphorusatom with a phosphorus-oxygen double bond (P═O), wherein two or threephotoreactive groups are covalently bound to the phosphorus atom. Inanother embodiment, the linking group comprises at least two phosphorusatoms, wherein at least one phosphorus atom includes a phosphorus-oxygendouble bond (P═O), and at least one or two photoreactive groups arecovalently bound to each phosphorus atom.

In a more particular embodiment, the linking agent can be represented bythe formula:

wherein Photo¹ and Photo², independently, represent one or morephotoreactive groups, wherein the degradable linking agent comprises acovalent linkage between at least one photoreactive group and thelinking group, wherein the covalent linkage between at least onephotoreactive group and the linking group is interrupted by at least oneheteroatom and R is alkyl or aryl, a photoreactive group, hydroxyl orsalt thereof, or a combination thereof. In one embodiment, the hydroxylsalt includes a counterion that is lithium, sodium, potassium, or acombination thereof. In a more particular embodiment, R is cyclic,linear or branched, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof. In a more particularembodiment, R is phenyl, methyl, ethyl, isopropyl, t-butyl, or acombination thereof.

In another embodiment, the degradable linking agent can be representedby formula:

wherein Photo¹ and Photo² independently, represent one or morephotoreactive groups, wherein the degradable linking agent comprises acovalent linkage between at least one photoreactive group and thelinking group, wherein the covalent linkage between at least onephotoreactive group and the linking group is interrupted by at least oneheteroatom and R is alkyl or aryl, a photoreactive group (wherein thecovalent linkage between the photoreactive group and the linking groupmay be interrupted by at least one heteroatom), hydroxyl or saltthereof, or a combination thereof. In one embodiment, the hydroxyl saltincludes a counterion that is lithium, sodium, potassium, or acombination thereof. In a more particular embodiment, R is cyclic,linear or branched, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof. In one embodiment, R isphenyl, methyl, ethyl, isopropyl, t-butyl, or a combination thereof.

In another embodiment, the degradable linking agent can be representedby the formula:

wherein Photo¹ and Photo², independently, represent one or morephotoreactive groups, wherein the degradable linking agent comprises acovalent linkage between at least one photoreactive group and thelinking group, wherein the covalent linkage between at least onephotoreactive group and the linking group is interrupted by at least oneheteroatom; Y represents a linker that can be null (i.e., not present,such that the linking group includes a direct P—P bond), N or O, linearor branched C₁-C₁₀ alkyl, or a combination thereof; and R¹ and R² areindependently alkyl, aryl, a photoreactive group (wherein the covalentlinkage between the photoreactive group and the linking group can beinterrupted by at least one heteroatom), hydroxyl or salt thereof, or acombination thereof. In one embodiment, Y is selected from O, CH₂,OCH₂O, OCH₂CH₂O and O(CH₂CH₂O)_(n), wherein n is an integer between 1and 5, between 1 and 10, between 1 and 15, between 1 and 20, between 1and 25, or between 1 and 30. In one embodiment, the hydroxyl saltcounterion is lithium, sodium, potassium, or a combination thereof. In amore particular embodiment, R¹ and R² are independently, cyclic, linearor branched hydrocarbon, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof. In one embodiment, R¹ and R²are independently phenyl, methyl, ethyl, isopropyl, t-butyl, or acombination thereof. In general, a longer hydrocarbon chain between thetwo phosphorus atoms will tend to increase the flexibility of thelinking agent and may facilitate crosslinking between a greater numberof polymers than a linking agent with a shorter carbon chain, since thereactive photoreactive groups can react with polymers located fartherapart from one another. In one embodiment, Y can be O, CH₂, OCH₂CH₂O andO(CH₂CH₂O)_(n) wherein n is an integer between 1 and 5, between 1 and10, between 1 and 15, between 1 and 20, between 1 and 25, or between 1and 30. One embodiment is shown below

in which R¹, R², R⁴ and R⁵ can be any substitution, including but notlimited to H, alkyl, halogen, amine, hydroxyl, or a combination thereof;R³ can be any substitution, including but not limited to O, alkyl, or acombination thereof; and each X can independently be O, N. Se, S, alkyl,or a combination thereof. In one embodiment, the linking agent includesone or more phosphorester bonds and one or more phosphoramide bonds, andcan be represented by the formula:

wherein X and X² are, independently, O, N, Se, S or alkyl; R¹ and R² areindependently, one or more photoreactive groups, and X³ is O, N, Se, S,alkyl or aryl; R³ is alkyl or aryl, including, but not limited tocyclic, linear or branched, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof. In a more particularembodiment, R³ is phenyl, methyl, ethyl, isopropyl, t-butyl, or acombination thereof. R³ can also be a photoreactive group or a hydroxylor salt thereof. In one embodiment, the hydroxyl salt counterion islithium, sodium, potassium, or a combination thereof.

In one embodiment, the linking agent comprises a triphosphorester, whichcan be represented by the formula.

wherein R¹ and R² are independently, one or more photoreactive groups,and R³ is alkyl or aryl, including, but not limited to cyclic, linear orbranched, saturated or unsaturated, aromatic or heteroaromatic, or acombination thereof. In a more particular embodiment, R³ is phenyl,methyl, ethyl, isopropyl, t-butyl, or a combination thereof. R³ can alsobe a photoreactive group or hydrogen, or a hydroxyl salt. In oneembodiment, the hydroxyl salt counterion is lithium, sodium, potassium,or a combination thereof.

Some specific embodiments include the following linking agents:

-   (a) bis(4-benzoylphenyl)hydrogen phosphate:

-   (b) sodium bis(4-benzoylphenyl phosphate):

-   (c) tris(4-benzoylphenyl) phosphate):

-   (d) tetrakis(4-benzoylphenyl)methylenebis(phosphonate)

In another embodiment, the linking agent comprises a triphosphoramide,which can be represented by the formula.

wherein R¹-R⁶ are independently, a photoreactive group, a hydroxyl orsalt thereof, alkyl or aryl, or a combination thereof, wherein at leasttwo of R¹-R⁶ are, independently, a photoreactive group. In oneembodiment, the hydroxyl salt counterion is lithium, sodium, potassium,or a combination thereof. In a more particular embodiment, R¹-R⁶ areindependently cyclic, linear or branched, saturated or unsaturated,aromatic or heteroaromatic, or a combination thereof. In a moreparticular embodiment, R¹-R⁶ are, independently, phenyl, methyl, ethyl,isopropyl, t-butyl, or a combination thereof.

Linking Element

The degradable linking agent can be formed using any suitable reactionpathway. In one embodiment, the degradable linking agent is formed byreacting a functionalized linking element with one or more, typicallytwo or more photoreactive groups. As used herein, the term “linkingelement” refers to the linking group component of the degradable linkingagent before it is bonded to one or more photoreactive groups. The term“functionalized linking element” is used to indicate that the linkingelement includes one or more reactive functional groups. In oneembodiment, the linking element includes one or more halogen functionalgroups. The term “halogen” refers to fluorine, chlorine, bromine, oriodine functional groups. In another embodiment, the linking elementincludes one or more trifluoromethanesulfonate (CF₃SO₃—) functionalgroups.

In one embodiment, the linking element includes one or more siliconatoms. In one embodiment, the linking element includes one or morehalogen substituents, such as fluorine, chlorine, bromine, iodine, andcombinations thereof. In another embodiment, the linking elementincludes at least two halogen substituents. In another embodiment, thelinking element includes one or more trifluoromethanesulfonate(triflate) substituents. In another embodiment, the linking elementincludes at least two triflate substituents. In a more particularembodiment, the linking element includes one silicon atom with at leasttwo halogen or triflate substituents. In another embodiment, the linkingelement includes at least two silicon atoms. In a more particularembodiment, the linking element includes two silicon atoms, wherein eachsilicon atom includes at least one halogen or triflate substituent. Inone embodiment, the linking element can be represented by the formulaSi—Y—Si, wherein Y represents a linker that can be null, an amine,ether, linear or branched C₁-C₁₀ alkyl, or a combination thereof,wherein each silicon atom includes at least one halogen or triflatesubstituent. In one embodiment, Y is selected from O, CH₂, OCH₂CH₂O andO(CH₂CH₂O)_(n), wherein n is an integer between 1 and 5, between 1 and10, between 1 and 15, between 1 and 20, between 1 and 25, or between 1and 30.

In one embodiment, the linking element can be represented by the formula

wherein X¹ and X² are independently halogen, such as fluorine, chlorine,bromine, iodine; trifluoromethanesulfonate; or a combination thereof andn is an integer between 1 and 10. R₁-R₄ are independently alkyl or aryl,including, but not limited to cyclic, linear or branched, saturated orunsaturated, aromatic or heteroaromatic, or a combination thereof. In amore particular embodiment, R¹-R⁴ are independently phenyl, methyl,ethyl, isopropyl, t-butyl, or a combination thereof. In anotherembodiment, R¹-R⁴ can also be, independently, halogen. In yet anotherembodiment, R¹-R⁴ can also be, independently, hydroxyl or salt thereof.In one embodiment, the hydroxyl salt includes a counterion that islithium, sodium, potassium, or a combination thereof.

In another embodiment, the linking element can be represented by theformula

wherein X¹ and X² are independently halogen; such as fluorine, chlorine,bromine, and iodine; or trifluoromethanesulfonate; R¹ and R² areindependently alkyl or aryl, including, but not limited to cyclic,linear or branched, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof. In a more particularembodiment, R¹ and R² are independently phenyl, methyl, ethyl,isopropyl, t-butyl, or a combination thereof. R¹ and R² can also be,independently, halogen, hydroxyl or hydroxyl salt. In one embodiment,the hydroxyl salt includes lithium, sodium, potassium, or a combinationthereof as a counterion.

In another embodiment, the linking element includes one or morephosphorous atoms. In one embodiment, the linking element comprises atleast one phosphorus atom with a phosphorus-oxygen double bond (P═O),wherein at least one halogen or trifluoromethanesulfonate substituent isbound to at least one phosphorus atom. In another embodiment, thelinking element comprises one phosphorus atom with a phosphorus-oxygendouble bond (P═O), wherein two or three halogen ortrifluoromethanesulfonate substituents are, independently, covalentlybound to the phosphorus atom. In another embodiment, the linking elementcomprises at least two phosphorus atoms, wherein at least one phosphorusatom includes a phosphorus-oxygen double bond (P═O), and at least one ortwo halogen or trifluoromethanesulfonate substituents are covalentlybound to each phosphorus atom. In a more particular embodiment, thelinking element comprises two phosphorus atoms.

In a more particular embodiment, the linking element can be representedby the formula

wherein X¹ and X² are independently halogen; such as fluorine, chlorine,bromine, and iodine; or trifluoromethanesulfonate; and R is alkyl oraryl, halogen, hydroxyl or a hydroxyl salt, or a combination thereof. Inone embodiment, the hydroxyl salt includes a counterion that is lithium,sodium, potassium, or a combination thereof. In a more particularembodiment, R is cyclic, linear or branched, saturated or unsaturated,aromatic or heteroaromatic, or a combination thereof. In a moreparticular embodiment, R is phenyl, methyl, ethyl, isopropyl, t-butyl,or a combination thereof.

In another embodiment, the degradable linking element can be representedby formula:

wherein X¹ and X² are independently halogen, such as fluorine, chlorine,bromine, and iodine; or trifluoromethanesulfonate and R is alkyl oraryl, halogen, trifluoromethanesulfonate, hydroxyl or salt thereof, or acombination thereof. In one embodiment, the hydroxyl salt includes acounterion that is lithium, sodium, potassium, or a combination thereof.In a more particular embodiment, R is cyclic, linear or branched,saturated or unsaturated, aromatic or heteroaromatic, or a combinationthereof. In one embodiment, R¹ and R² are independently phenyl, methyl,ethyl, isopropyl, t-butyl, or a combination thereof.

In another embodiment, the degradable linking element can be representedby the formula:

wherein X¹ and X² are independently halogen, such as fluorine, chlorine,bromine, and iodine; or trifluoromethanesulfonate, Y represents a linkerthat can be null, an amine, an ether, linear or branched C₁-C₁₀ alkyl,or a combination thereof; and R¹ and R² are independently alkyl, aryl,halogen, hydroxyl or salt thereof, or a combination thereof. In oneembodiment, Y is selected from O, CH₂, OCH₂CH₂O and O(CH₂CH₂O)_(n),wherein n is an integer between 1 and 5, between 1 and 10, between 1 and15, between 1 and 20, between 1 and 25, or between 1 and 30. In oneembodiment, the hydroxyl salt counterion is lithium, sodium, potassium,or a combination thereof. In a more particular embodiment, R¹ and R² areindependently, cyclic, linear or branched hydrocarbon, saturated orunsaturated, aromatic or heteroaromatic, or a combination thereof. Inone embodiment, R¹ and R² are independently phenyl, methyl, ethyl,isopropyl, t-butyl, or a combination thereof.

Methods of Making

The degradable linking agent can be formed using any suitable reactionpathway. In one embodiment, the degradable linking agent is formed byreacting a halogenated or triflated linking element with one or more,typically two or more photoreactive groups, for example, by anucleophilic substitution reaction. As used herein, the term “linkingelement” refers to the linking group component of the degradable linkingagent before it is bonded to a photoreactive group. As used herein, theterm “halogenated” refers to the presence of one or more halogensubstituents, including fluorine, chlorine, bromine, or iodine, whichcan, under the appropriate conditions, serve as a leaving group in anucleophilic substitution reaction. As used herein, the term triflated,refers to the presence of one or more trifluoromethanesulfonate(CF₃SO₃—) functional groups that can, under the appropriate conditions,serve as a leaving group in an nucleophilic substitution reactions.

Examples of nucleophilic substitution reactions include, but are notlimited to the following. In one embodiment, a degradable linking agentis formed by connecting two molecules of 4-hydroxybenzophenone with ahalogenated disilane linking element by a nucleophilic substitutionreaction to form a degradable linking agent as shown in FIG. 1. Inanother embodiment, a degradable linking agent is formed by connectingtwo molecules of 4-hydroxybenzophenone with a halogenated di-silyllinking element by a nucleophilic substitution reaction to form adegradable linking agent as shown in FIG. 2. In yet another embodiment,a degradable linking agent is formed by connecting two molecules of4-hydroxybenzophenone with a dichlorosilane linking element by anucleophilic substitution reaction to form a degradable linking agent asshown in FIG. 3. In another embodiment, a degradable linking agent isformed by reacting phosphorous trichloride with 4-hydroxybenzophenone ina presence of base such as pyridine or diisopropylethyl amine as shownin FIG. 4. In another embodiment, a degradable linking agent is formedby reacting phosphoryl chloride with 4-hydroxybenzophenone in a presenceof a base such as pyridine or diisopropylethyl amine as shown in FIG. 5.In another embodiment, a degradable linking agent is formed by reactingdiphosphorous halide with 4-hydroxybenzophenone as shown in FIG. 6. Inanother embodiment, a degradable linking agent is formed by converting4-hydroxybenzophenone into its phosphite derivative by reacting thehydroxybenzophenone with PCl₃. The resulting phosphite is reacted withhalide, such as chlorine, using Michaelis-Arbusov conditions to generatethe degradable linking agent as shown in FIG. 7. In an alternatepathway, the degradable linking agent is formed using phosphite as astarting material as shown in FIG. 8.

Photoreactive Groups

As used herein, the term “photoreactive group” refers to a moleculehaving one or more functional groups that are capable of responding to aspecific applied external stimulus to undergo active specie generationand form a covalent bond with an adjacent chemical structure, which canbe provided by the same or a different molecule. Photoreactive groupsare those groups of atoms in a molecule that retain their covalent bondsunchanged under conditions of storage but that, upon activation by anexternal energy source, form one or more covalent bonds with othermolecules. In one embodiment, the photoreactive groups can generateactive species such as free radicals upon absorption of electromagneticenergy. Photoreactive groups can be chosen to be responsive to variousportions of the electromagnetic spectrum, including, for example, theultraviolet and visible portions of the spectrum. Photoreactive groupsare described, for example, in U.S. Pat. No. 5,002,582, the disclosureof which is incorporated herein by reference.

In one embodiment, the photoreactive group includes a substituentcapable of reacting with halogenated or triflated linking element. In amore particular embodiment, the photoreactive group contains a hydroxyl(—OH) or amine (—NR₂) substituent, wherein the amine substituent can bea primary amine or a secondary amine.

In one embodiment, the functionalized photoreactive group can berepresented by the formula Photo-Y—OH, wherein Y represents a linkerthat can be null, an amine, an ether, linear or branched C₁-C₁₀ alkyl,or a combination thereof. In one embodiment, Y is selected from O, CH₂,OCH₂CH₂O and O(CH₂CH₂O)_(n), wherein n is an integer between 1 and 5,between 1 and 10, between 1 and 15, between 1 and 20, between 1 and 25,or between 1 and 30. In another embodiment, the functionalizedphotoreactive group can be represented by the formula

wherein Y represents a linker that can be null, an amine, an ether,linear or branched C₁-C₁₀ alkyl, or a combination thereof and R₁ and R₂are independently alkyl or aryl, including, but not limited to cyclic,linear or branched, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof. In a more particularembodiment, R₁ and R₂ are independently phenyl, methyl, ethyl,isopropyl, t-butyl, or a combination thereof. In one embodiment, Y isselected from O, CH₂, OCH₂CH₂O and O(CH₂CH₂O)_(n), wherein n is aninteger between 1 and 5, between 1 and 10, between 1 and 15, between 1and 20, between 1 and 25, or between 1 and 30.

In one embodiment, the halogenated linking element reacts with the amineor hydroxyl substituent on the photoreactive group to provide adegradable linking agent. One advantage of a photoreactive group with areactive amine substituent, is that the amine substituent is able toreact with additional halogen substituents on other linking elements,which can result in the amine substituent of a first photoreactive groupbinding to more than one linking element. For example, a firstphotoreactive group can be attached to a first linking group by a firstamine and a second photoreactive group can then be attached to the firstlinking agent and the first photoreactive group by the same (first)amine. If desired, the degradable linking agent can also include a thirdphotoreactive group attached to the first linking group by a secondamine and, if desired, a fourth photoreactive group can also be attachedto the first linking agent and the third photoreactive group by thesecond amine. One example is shown below, wherein R independently, canbe alkyl or aryl, including but not limited to cyclic, linear orbranched, saturated or unsaturated, aromatic or heteroaromatic, or acombination thereof. In a more particular embodiment, R can be,independently, a photo reactive group, wherein the covalent linkagebetween the photoreactive group and the linking group is interrupted byat least one heteroatom; phenyl, methyl, ethyl, isopropyl, t-butyl, or acombination thereof:

In one embodiment, the photoreactive group includes a photoreactive arylketone, such as acetophenone, benzophenone, anthraquinone, anthrone, andanthrone-like heterocycles (i.e., heterocyclic analogs of anthrone suchas those having N, O, or S in the 10-position), or their substituted(e.g., ring substituted) derivatives. Examples of aryl ketones includeheterocyclic derivatives of anthrone, including acridone, xanthone, andthioxanthone, and their ring substituted derivatives. One exampleincludes thioxanthone, and its derivatives, having excitation energiesgreater than about 360 nm. In one embodiment, the photoreactive group isa functionalized benzophenone with an amine or hydroxyl substituent atpositions 3 or 4 (i.e., 3- or 4-aminobenzophenone or 3- or4-hydroxybenzophenone). As discussed above, the functionalizedbenzophenone can include a linker between the benzophenone photoreactivegroup and the amine or hydroxyl substituent. Examples of linkers includean amine, an ether, linear or branched C₁-C₁₀ alkyl, or a combinationthereof.

The functional groups of such ketones are readily capable of undergoingthe activation/inactivation/reactivation cycle described herein.Benzophenone is one example of a photoreactive moiety that is capable ofphotochemical excitation with the initial formation of an excitedsinglet state that undergoes intersystem crossing to the triplet state.The excited triplet state can insert into carbon-hydrogen bonds byabstraction of a hydrogen atom (from a support surface, for example),thus creating a radical pair. Subsequent collapse of the radical pairleads to formation of a new carbon-carbon bond. If a reactive bond(e.g., carbon-hydrogen) is not available for bonding, the ultravioletlight-induced excitation of the benzophenone group is reversible and themolecule returns to ground state energy level upon removal of the energysource. Photoactivatable aryl ketones such as benzophenone andacetophenone are subject to multiple reactivation in water and mayincrease coating efficiency.

The azides constitute one class of photoreactive groups and includederivatives based on arylazides (C₆R₅N₃) such as phenyl azide andparticularly 4-fluoro-3-nitrophenyl azide, acyl azides (—CO—N₃) such asbenzoyl azide and p-methylbenzoyl azide, azido formates (—O—CO—N₃) suchas ethyl azidoformate, phenyl azidoformate, sulfonyl azides (—SO₂—N₃)such as benzenesulfonyl azide, and phosphoryl azides (RO)₂PON₃ such asdiphenyl phosphoryl azide and diethyl phosphoryl azide. Diazo compoundsconstitute another class of photoreactive groups and include derivativesof diazoalkanes (—CHN₂) such as diazomethane and diphenyldiazomethane,diazoketones (—CO—CHN₂) such as diazoacetophenone and1-trifluoromethyl-1-diazo-2-pentanone, diazoacetates (—O—CO—CHN₂) suchas t-butyl diazoacetate and phenyl diazoacetate, andbeta-keto-alpha-diazoacetates (—CO—CN₂—CO—O—) such as t-butyl alphadiazoacetoacetate. Other photoreactive groups include the diazirines(—CHN₂) such as 3-trifluoromethyl-3-phenyldiazirine, and ketenes(—CH═C═O) such as ketene and diphenylketene.

Upon activation of the photoreactive groups, the linking agents arecovalently bound to each other, to other molecules, or to a surface bycovalent bonds through residues of the photoreactive groups. Exemplaryphotoreactive groups, and their residues upon activation, are shown asfollows.

Photoreactive Group aryl azides amine (R—NH—R′) acyl azides amide(R—CO—NH—R′) azidoformates carbamate (R—O—CO—NH—R′) sulfonyl azidessulfonamide (R—SO₂—NH—R′) phosphoryl azides phosphoramide((RO)₂PO—NH—R′) diazoalkanes new C—C bond diazoketones new C—C bond andketone diazoacetates new C—C bond and ester beta-keto-alpha-diazoacetates new C—C bond and beta-ketoester aliphatic azo new C—C bonddiazirines new C—C bond ketenes new C—C bond photoactivated ketones newC—C bond and alcohol

Photoinitiation of free radicals can take place via various mechanisms,including photochemical intramolecular photocleavage, hydrogenabstraction, and redox reactions. In one embodiment, photoinitiationtakes place by hydrogen abstraction from the polymerizable groups.

Intramolecular photocleavage involves a homolytic alpha cleavagereaction between a carbonyl group and an adjacent carbon atom. This typeof reaction is generally referred to as a Norrish type I reaction.Examples of molecules exhibiting Norrish type I reactivity and useful ina polymeric initiating system include derivatives of benzoin ether andacetophenone. For example, in one embodiment wherein the linking agentis provided in the form of a quinone having adjacent carbonyl groups(e.g., camphorquinone), photoinitiation takes place via intramolecularbond cleavage.

A second mechanism, hydrogen abstraction, can be either intra- orintermolecular in nature. A system employing this mechanism can be usedwithout additional energy transfer acceptor molecules and by nonspecifichydrogen abstraction. However, this system is more commonly used with anenergy transfer acceptor, typically a tertiary amine, which results inthe formation of both aminoalkyl radicals and ketyl radicals. Examplesof molecules exhibiting hydrogen abstraction reactivity and useful in apolymeric initiating system, include analogs of benzophenone andcamphorquinone.

A third mechanism involves photosensitization reactions utilizingphotoreducible or photo-oxidizable dyes. In most instances,photoreducible dyes are used in conjunction with a reductant, typicallya tertiary amine. The reductant intercepts the induced triplet producingthe radical anion of the dye and the radical cation of the reductant.

In one embodiment, photoinitiation generates active species such as freeradicals, including nitrenes, carbenes, and excited states of ketonesupon absorption of electromagnetic energy. This excited photoinitiatorin turn abstracts hydrogen atoms from available sources in proximity tothe photoinitiator, e.g., polymerizable species, applied to the primedsurface. This hydrogen abstraction thus generates a free radical sitewithin the polymerizable species from which polymerization can proceed.

A typical free radical polymerization includes four steps: initiation,propagation, and termination. In initiation, a free radical derived froman initiator adds to a monomer molecule to form an active center. Otherinitiating reactions include addition to the head of the molecule orhydrogen abstraction, and the reaction mechanism depends upon thestructures of the radical and monomer. The propagation or growthreaction includes of the rapid addition of monomer molecules to theradical species. The most common mechanism of propagation occurs inhead-to-tail fashion. However, propagation may also occur inhead-to-head, tail-to-head, and tail-to-tail modes. In termination, thepolymer chain stops growing by the destruction of propagating radicals.Normally, in the absence of species that destroy radicals, chaintermination occurs by bimolecular interaction of radicals (e.g., radicalcombinations or disproportionation).

In one embodiment, the linking agent includes a conjugated cyclicdiketone having attached thereto, either directly or indirectly, one ormore substituents including negatively charged groups, and wherein eachketone group of the diketone is adapted to serve as a photoreactivemoiety capable of being activated in order to provide a free radical. Inone embodiment, the conjugated cyclic diketone is a quinone selectedfrom substituted and unsubstituted benzoquinone, camphorquinone,naphthoquinone, and anthraquinone.

Charged Groups

In one embodiment, the linking agent includes one or more charged groupsto improve properties such as water solubility, hemocompatability and/orantithrombogenicity. As used herein, a “charged” group generally refersto a group that is present in ionic form in solution, i.e., carries anelectrical charge under the conditions (e.g., pH) of use. The type andnumber of charged groups in a linking agent can vary. In one embodiment,the linking agent includes a sufficient number and type of chargedgroups to provide the agent with water solubility (at room temperatureand optimal pH) of at least about 0.1 mg/ml, at least about 0.5 mg/ml,and at least about 1 mg/ml. In one embodiment, the linking agent isconfigured for use in a surface coating process and has a solubilitylevel of at least about 0.1 mg/ml.

In one embodiment, one or more charged groups are introduced into thelinking agent by the inclusion of a hydroxyl salt, such as a lithium,sodium, potassium salt, or a combination thereof on the linking agent.

Surface Modification

In one embodiment, the degradable linking agent is used to form acoating on a substrate surface. In one embodiment, the coating ishydrophobic. In another embodiment, the coating is hydrophilic. Thecoating can be formed in any suitable manner, e.g., by simultaneous orsequential attachment of the linking agent and chemical compounds (e.g.,molecules bearing polymerizable groups) to a support surface. In oneembodiment, the method involves a two step process, involving sequentialsteps in which linking agent is first attached to the surface, afterwhich compounds are polymerized thereon using the photoinitator of theattached agent. One advantage of a sequential approach is thatphotopolymerization of this sort allows the generation of thin polymerlayers on the support surface. The resultant polymer layer is typicallyhighly adherent, uniform in thickness, and is highly durable. Moreover,solutions used to form the polymer layer can be applied (e.g., via insolution application, dip coating, spray coating, knife coating, androller coating) to any suitable support surface of any surfacemorphology. The resultant polymer layer, in turn, can be adapted tocover irregular surfaces as well as smooth, relatively uniform surfaces.The polymerizable species can also be attached to the support surfacesimultaneously with the linking agent, by providing suitable reactionconditions to allow such simultaneous attachment of the linking agentand polymerization of the polymerizable species.

The photoinitiator group (i.e., the second photoreactive group, orlatent reactive group) can be identical to, or different from, the firstphotoreactive group used to attach the linking agent to a supportsurface. In one embodiment, the first and second photoreactive groupsare adapted to be independently activated by light of differentwavelengths (e.g., ultraviolet light versus visible light).

Upon activation of the photoreactive groups in the presence of a supportsurface, the second photoreactive group(s) remain unbound to the supportsurface and revert to their inactive state (e.g., latent) in order toserve as photoinitiator groups. While not intending to be bound bytheory, it appears that the ability of a photoreactive group to remainunbound (and hence serve as a photoinitiator) is a factor, at least inpart, of various reaction conditions (e.g., time and intensity ofillumination wavelength, reagent concentration, etc.) and/orrestrictions imposed by the size and/or structure of the linking agentitself. The photoinitiator thus remains available to be subsequentlyactivated by a suitable energy source, and thereby initiatephotopolymerization.

In one embodiment, the linking agent described herein is applied to asurface having carbon-hydrogen bonds with which the photoreactive groupscan react to immobilize the linking agents. In one embodiment, thesupport surface provides abstractable hydrogen atoms suitable forcovalent bonding with the activated group. In another embodiment, thesurface can be modified (e.g., by pretreatment with a suitable reagent)to provide abstractable hydrogen atoms on the surface.

The method described herein is suitable for use in connection with avariety of support surfaces, including hydrogel polymers, silicone,polypropylene, polystyrene, poly(vinyl chloride), polycarbonate,poly(methyl methacrylate), parylene and any of the numerousorganosilanes used to pretreat glass or other inorganic surfaces. Thephotoreactive linking agents can be applied to surfaces in any suitablemanner (e.g., in solution or by dispersion), then photoactivated byuniform illumination to immobilize them to the surface. Examples ofsuitable hydrogel polymers are selected from silicone hydrogels,hydroxyethylmethacrylate polymers, and glyceryl methacrylate polymers.

Other suitable surface materials include polyolefins, polystyrenes,poly(methyl)methacrylates, polyacrylonitriles, poly(vinylacetates),poly(vinyl alcohols), chlorine-containing polymers such as poly(vinyl)chloride, polyoxymethylenes, polycarbonates, polyamides, polyimides,polyurethanes, phenolics, amino-epoxy resins, polyesters, silicones,cellulose-based plastics, and rubber-like plastics. See generally,“Plastics,” pp. 462-464, in Concise Encyclopedia of Polymer Science andEngineering, Kroschwitz, ed., John Wiley and Sons, 1990, the disclosureof which is incorporated herein by reference. In addition, supports suchas those formed of pyrolytic carbon and silylated surfaces of glass,ceramic, or metal are suitable for surface modification.

Such materials can be used to fabricate a number of devices capable ofbeing provided, either before, during and/or after their fabrication,with a polymer layer. Implant devices are one general class of suitabledevices, and include, but are not limited to, vascular devices such asgrafts, stents, catheters, valves, artificial hearts, and heart assistdevices; orthopedic devices such as joint implants, fracture repairdevices, and artificial tendons; dental devices such as dental implantsand fracture repair devices; ophthalmic devices such as lenses andglaucoma drain shunts; and other catheters, synthetic prostheses andartificial organs. Other suitable biomedical devices include dialysistubing and membranes, blood oxygenator tubing and membranes, blood bags,sutures, membranes, cell culture devices, chromatographic supportmaterials, biosensors, and the like.

Surface modification can be achieved using photopolymerization (e.g., byfree radical polymerization). In accordance with the present method, aselected surface is contacted with a linking agent, as described above.During and/or after application of the linking agent, the surface isilluminated with UV light of the appropriate wavelength, therebyactivating the photoreactive groups. The linking agent is thusimmobilized to the surface, by means of the first photoreactive groups(with the second photoreactive groups reverting to inactive form), andexcess linking agent can then be optionally washed away, leaving asurface primed with a base layer of linking agent.

The linking agent can be applied to the surface of interest in anysuitable manner. For example, the linking agent can be applied by dipcoating or by dispersing the agent on the surface (for example, by spraycoating). Suitable methods of application include application insolution, dip coating, spray coating, knife coating, and roller coating.In one embodiment, the linking agent is applied to the surface via spraycoating, as this application method provides increased density of thelinking agent on the support surface, thereby improving graftingdurability.

In the sequential approach described herein, a solution containingpolymerizable compounds can be applied to a primed surface. The solutioncan be illuminated in situ to activate the second photoreactive group(s)that serve as a photoinitiator(s), thus initiating free radicalpolymerization via hydrogen abstraction. In one embodiment,photopolymerization takes place in an inert atmosphere, since oxygeninterferes with free radical polymerization. Deoxygenation can takeplace using an inert gas such as nitrogen.

Once the system has been deoxygenated, the surface can again beilluminated with UV light of the appropriate wavelength. This secondillumination thus activates the second photoreactive group(s) serving asa photoinitiator(s) of free radical polymerization. In one embodiment,illumination generates the excited state of the photoreactive group,allowing the excited molecule to abstract a hydrogen from availablesources, e.g., molecules bearing polymerizable groups. Such hydrogenabstraction generates a free radical site, from which polymerization canproceed.

The method includes steps of providing a support surface and applying alinking agent to the support surface. In one embodiment, the methodfurther includes a step of illuminating the linking agent tophotochemically attach the linking agent to the surface. In oneembodiment, the method further includes a step of providing a pluralityof molecules bearing free radical polymerizable groups and illuminatingthe molecules bearing polymerizable groups and the linking agent toinitiate polymerization of the molecules bearing polymerizable groups onthe support surface.

In one embodiment the linking agent is used in connection with aplurality of molecules, each bearing one or more polymerizable groups.In accordance with this embodiment, the photoreactive group serves as aninitiator to initiate polymerization of the polymerizable groups. Asused herein, “polymerizable group” refers to a group that is adapted tobe polymerized by initiation via free radical generation, and byphotoinitiators activated by visible or long wavelength ultravioletradiation.

A variety of polymerizable compounds are suitable for use as with thelinking agent described herein. In one embodiment, the polymerizationproducts (e.g., a polymer layer resulting from free radicalpolymerization) is hydrophilic or is capable of being modified toprovide hydrophilic characteristics at appropriate reaction conditions(e.g., pH). Moreover, the polymerizable groups of such compounds caninclude those adapted to participate in free-radical polymerization. Inone embodiment, compounds include at least one free-radicalpolymerizable component (e.g., a vinyl group), and at least onefunctional group with a high affinity for water. Such functional groupswith a high affinity for water can be negatively charged, positivelycharged, or electrically neutral.

Suitable polymerizable compounds are selected from monomericpolymerizable molecules (e.g., organic monomers), and macromericpolymerizable molecules (e.g., organic macromers). As used herein,“macromer” shall refer to a macromolecular monomer having a molecularweight of about 250 to about 25,000, and from about 1,000 to about5,000.

Suitable polymerizable compounds can contain electrically neutralhydrophilic functional units, for example, acrylamide and methacrylamidederivatives. Examples of suitable monomers containing electricallyneutral hydrophilic structural units include acrylamide, methacrylamide,N-alkylacrylamides (e.g., N,N-dimethylacrylamide or methacrylamide,N-vinylpyrrolidinone, N-vinylacetamide, N-vinyl formamide,hydroxyethylacrylate, hydroxyethylmethacrylate, hydroxypropyl acrylateor methacrylate, glycerolmonomethacrylate, and glycerolmonoacrylate).

Alternatively, suitable polymerizable compounds containing electricallyneutral hydrophilic functional units include molecules whose polymers,once formed, can be readily modified (e.g., hydrolyzed by the additionof ethylene oxide) to provide products with enhanced affinity for water.Examples of suitable monomers of this type include glycidyl acrylate ormethacrylate, whose polymers bear epoxy groups that can be readilyhydrolyzed to provide glycol structures having a high affinity forwater.

Examples of suitable monomeric polymerizable molecules that arenegatively charged at appropriate pH levels include acrylic acid,methacrylic acid, maleic acid, fumaric acid, itaconic acid, AMPS(acrylamidomethylpropane sulfonic acid), vinyl phosphoric acid,vinylbenzoic acid, and the like.

Alternatively, suitable monomeric polymerizable molecules that arenegatively charged at appropriate pH levels include molecules whosepolymers, once formed, can be readily modified (e.g., by hydrolysis viathe addition of ethylene oxide) to provide products with enhancedaffinity for water. Examples of suitable monomers of this type includemaleic anhydride, whose polymers bear anhydride groups that can bereadily hydrolyzed to provide carboxylic acid groups, or can be readilyreacted with amines to provide amide/acid structures with high affinityfor water, and polymerized vinyl esters.

Examples of suitable monomeric molecules that are positively charged atappropriate pH levels include 3-aminopropylmethacrylamide (APMA),methacrylamidopropyltrimethylammonium chloride (MAPTAC),N,N-dimethylaminoethylmethacrylate, N,N-diethylaminoethylacrylate, andthe like.

Alternatively, suitable positively charged monomeric polymerizablemolecules include those molecules that can be readily modified (e.g., byhydrolysis via the addition of ethylene oxide) to provide products withenhanced affinity for water as well as a positive charge, e.g., glycidylmethacrylate whose polymeric products can be reacted with amines (e.g.,ethylamine), to provide hydroxyamino compounds. In some cases, thesematerials will contain a structural unit with an inherent positivecharge, as for example with fully quaternized ammonium structures. Inother cases, the positively charged structural unit will exist atcertain pH values, particularly at acidic pH values.

In an alternative embodiment, the polymerizable compounds includemacromeric polymerizable molecules. Suitable macromers can besynthesized from monomers such as those illustrated above. According toone embodiment, polymerizable functional components (e.g., vinyl groups)of the macromer can be located at either terminus of the polymer chain,or at one or more points along the polymer chain, in a random ornonrandom structural manner.

The number of free-radical polymerizable groups per molecule can bevaried according to the application. For example, a macromer with justone free-radical polymerizable unit can be used. In other instances,however, a macromer with more than one, e.g., two or more polymerizableunits per macromer can be used. Additionally, the macromer can containstructural features to provide improved affinity for water in a mannertypically unavailable in small molecule structures (e.g., hydrophilicpoly(ethylene glycol) materials).

Examples of suitable macromeric polymerizable compounds includemethacrylate derivatives, monoacrylate derivatives, and acrylamidederivatives. Macromeric polymerizable compounds include poly(ethyleneglycol)monomethacrylate, methoxypoly(ethylene glycol)monomethacrylate,poly(ethylene glycol)monoacrylate, monomethyacrylamidopoly(acrylamide),poly(acrylamide-co-3-methacrylamidopropylacrylamide),poly(vinylalcohol)monomethacrylate, poly(vinylalcohol)monoacrylate,poly(vinylalcohol)dimethacrylate, and the like.

Such macromers can be prepared, for instance, by first synthesizing ahydrophilic polymer of the desired molecular weight, followed by apolymer modification step to introduce the desired level ofpolymerizable (e.g., vinyl) functional units. For example, acrylamidecan be copolymerized with specific amounts of3-aminopropylmethacrylamide comonomer, and the resulting copolymer canthen be modified by reaction with methacrylic anhydride to introduce themethacrylamide functional units, thereby producing a useful macromer.

Poly(ethylene glycol) of a desired molecular weight can be synthesizedor purchased from a commercial source, and modified (e.g., by reactionwith methacrylyl chloride or methacrylic anhydride) to introduce theterminal methacrylate ester units to produce a suitable macromer. Someapplications can benefit by use of macromers with the polymerizableunits located at or near the terminus of the polymer chains, whereasother uses can benefit by having the polymerizable unit(s) located alongthe hydrophilic polymer chain backbone.

Such monomeric and macromeric polymerizable molecules can be used aloneor in combination with each other, including for instance, combinationsof macromers with other macromers, monomers with other monomers, ormacromers combined with one or more small molecule monomers capable ofproviding polymeric products with the desired affinity for water.Moreover, the above polymerizable compounds can be provided in the formof amphoteric compounds (e.g., zwitterions), thereby providing bothpositive and negative charges.

Biodegradable Polymer Foams

In another embodiment, the linking agent can be used in connection witha composition that is capable of in situ polymerization. In oneembodiment, the linking agent can be used in connection with abiocompatible, biodegradable polymer foam. Biodegradable foam used forthe treatment of wounds are described, for example, in US PatentPublication No. 2009/0093550, the disclosure of which is herebyincorporated by reference herein in its entirety.

In one embodiment, a biodegradable foam is formed using an “applicationcomposition” that includes a polymerizable component, a polymerizationinitiator, and a gas-releasing component. Suitable polymerizationinitiators include photoinitiators, including the photoreactive groupsof the linking agent described herein. An application composition can beused to form biocompatible foam in situ, or as a pre-formed foam.

The biocompatible polymer foams can be formed from macromers thatinclude “polymerizable group(s),” which generally refers to chemicalgroups that are polymerizable in the presence of free radicals. Apolymerizable group generally includes a carbon-carbon double bond,which can be an ethylenically unsaturated group or a vinyl group. Uponinitiation of a polymerization reaction in the application composition,the polymerizable groups, are activated by free radical propagation inthe composition, and covalently bonded with other polymerizable groups.As a result of the covalent bonding a crosslinked polymeric matrix isformed. Gas bubbles are generated in the application composition byfoaming agents while polymerization of the macromers (which causespolymer matrix formation) is occurring. As a result, a foam is formed,with air pockets (also referred to herein as “cells”) partially orcompletely surrounded by a wall of the crosslinked polymeric matrix.

Examples of polymerizable groups include, but are not limited to,acrylate groups, methacrylate groups, ethacrylate groups, 2-phenylacrylate groups, acrylamide groups, methacrylamide groups, itaconategroups, and styrene groups. In some aspects the macromers of theinvention include one or more methacrylate group(s).

Polymerizable groups can be “pendent” from the macromer at more than onelocation along the polymer backbone. In some cases the polymerizablegroups are randomly located along the length of the polymer backbone.Such randomly spacing typically occurs when the macromer is preparedfrom a polymer having reactive groups along the length of the polymer,and the polymer is reacted with a limited molar quantity of a compoundhaving the polymerizable group. For example, polysaccharides describedherein have hydroxyl groups along the length of the polysaccharide, anda portion of these hydroxyl groups are reacted with a compound having ahydroxyl-reactive group and a polymerizable group.

In other cases one or more polymerizable groups are pendent from themacromer at one or more defined locations along the polymer backbone.For example, a polymer used for the synthesis of the macromer can have areactive group at its terminus, or reactive groups at its termini. Manypolymers prepared from monomers with reactive oxygen-containing groups(such as oxides) have hydroxyl-containing terminal ends which can bereacted with a compound having a hydroxyl-reactive group and apolymerizable group to provide the macromer with polymerizable groups atits termini.

The macromers are based on biocompatible polymers. The term“biocompatible” (which also can be referred to as “tissue compatible”)generally refers to the inability of a component, composition, orarticle to promote a measurably adverse biological response in the body.A biocompatible component, composition, or article can have one or moreof the following properties: non-toxic, non-mutagenic, non-allergenic,non-carcinogenic, and/or non-irritating. A biocompatible component,composition, or article, in the least, can be innocuous and tolerated bythe body. A biocompatible component, by itself, may also improve one ormore functions in the body.

EXAMPLES Example 1 Preparation of a Disilane Degradable Linking Agent

A degradable linking agent with the formula shown above can be preparedas follows:

4-hydroxybenzophenone (0.992 g) is placed in an oven-dried 50 mLround-bottom flask under inert atmosphere. Anhydrous DCM (30 mL) andpyridine (0.5 mL) is added to the reaction mixture. The reaction mixtureis allowed to stir at room temperature for 5 min.1,8-bis(chlorodimethylsilyl)octane (0.786 g) is added at once viasyringe and the reaction mixture is allowed to stir for additional 16 hat room temperature. Product is purified by column chromatography usingsilica gel.

Example 2 Preparation of a Monosilane Degradable Linking Agent

A degradable linking agent with the formula shown above was prepared asfollows:

4-hydroxybenzophenone (2 g) was placed in an oven-dried 100 mLround-bottom flask under inert atmosphere. Anhydrous DCM (50 mL) andpyridine (1.22 mL) was added to the reaction mixture. The reactionmixture is allowed to stir at room temperature for 5 min.Diisopropyldichlorosilane (1 g) was added at once via syringe andreaction mixture was allowed to stir for additional 16 h at roomtemperature. The reaction mixture was filtered and washed with DI water(2×25 mL), 0.5 N HCL (25 mL), DI water (25 mL), sat. aq. NaHCO₃ (25 mL)and DI water (25 mL). Solution was dried over Na₂SO₄ and solvent wasevaporated in vacuo. Product was further purified by columnchromatography using silica gel.

Example 3 Preparation of a Disilane Degradable Linking Agent

A degradable linking agent with the formula shown above can be preparedas follows:

4-aminobenzophenone (2 eq) is placed in an oven-dried round-bottom flaskunder inert atmosphere. Anhydrous DCM and pyridine (2.5 eq) is added tothe reaction mixture. The reaction mixture is allowed to stir at roomtemperature for 5 min. 1,2-bis(chlorodimethylsilyl)methane (1 eq) isadded at once via syringe and the reaction mixture is allowed to stirfor additional 16 h at room temperature. Multi-functional structures aremade by reacting more than 1 eq of 1,2-bis(chlorodimethylsilyl)methanewith 4-aminobenzophenone to form a degradable linking agent havingmultiple photoreactive groups.

Example 4 Preparation of a Bis-phosphorous Degradable Linking Agent

A degradable linking agent is formed by reacting methylenebis(phosphonicdichloride) (1 eq) with 4-hydroxybenzophenone (2 eq) in anhydrous DCMusing pyridine (2.5 eq) as a base. The resulting product can beconverted into its salt to increase water solubility.

It should be noted that, as used in this specification and the appendedclaims, the singular forms “a,” “an,” and “the” include plural referentsunless the content clearly dictates otherwise. It should also be notedthat the term “or” is generally employed in its sense including “and/or”unless the content clearly dictates otherwise.

The foregoing discloses embodiments of the invention. In theSpecification and claims, the term “about” is used to modify, forexample, the quantity of an ingredient in a composition, concentration,volume, process, and similar values and ranges thereof, to describevarious embodiments of the disclosure. The term “about” refers tovariation in the numerical quantity that can occur, for example, throughtypical measuring and handling procedures used for making compounds,compositions, concentrates or use formulations; through inadvertenterror in these procedures; through differences in the manufacture,source, or purity of starting materials or ingredients used to carry outthe methods, and like proximate considerations. The term “about” alsoencompasses amounts that differ due to aging of a formulation with aparticular initial concentration or mixture, and amounts that differ dueto mixing or processing a formulation with a particular initialconcentration or mixture. Where modified by the term “about” the claimsappended hereto include equivalents to these quantities.

It should also be noted that, as used in this specification and theappended claims, the phrase “configured” describes a system, apparatus,or other structure that is constructed or configured to perform aparticular task or adopt a particular configuration. The phrase“configured” can be used interchangeably with other similar phrases suchas “arranged”, “arranged and configured”, “constructed and arranged”,“constructed”, “manufactured and arranged”, and the like.

All publications and patent applications in this specification areindicative of the level of ordinary skill in the art to which thisinvention pertains. All publications and patent applications are hereinincorporated by reference to the same extent as if each individualpublication or patent application was specifically and individuallyindicated by reference.

This application is intended to cover adaptations or variations of thepresent subject matter. It is to be understood that the abovedescription is intended to be illustrative, and not restrictive. Itshould be readily apparent that any one or more of the design featuresdescribed herein may be used in any combination with any particularconfiguration. With use of the metal injection molding process, suchdesign features can be incorporated without substantial additionalmanufacturing costs. That the number of combinations are too numerous todescribe, and the present invention is not limited by or to anyparticular illustrative combination described herein. The scope of thepresent subject matter should be determined with reference to theappended claims, along with the full scope of equivalents to which suchclaims are entitled.

What is claimed is:
 1. A method of coating a support surface with adegradable linking agent in order to provide the support surface withone or more latent reactive groups, the method comprising: a) providingthe support surface; b) applying to the support surface the degradablelinking agent, wherein the degradable linking agent comprises a formulaselected from:

wherein Photo¹ and Photo², independently, represent a photoreactivegroup; n is an integer between 1 and 10; and R¹-R⁴ are independentlycyclic, linear or branched, saturated or unsaturated, aromatic orheteroaromatic, a photoreactive group, hydroxyl or salt thereof, or acombination thereof;

wherein Photo¹ and Photo², independently, represent one or morephotoreactive groups; and R¹ and R² are independently a photoreactivegroup, hydroxyl or salt thereof, or a combination thereof;

wherein Photo¹ and Photo², independently, represent one or morephotoreactive groups and R is hydroxyl or a salt thereof, or acombination thereof; and

wherein Photo¹ and Photo², independently, represent a photoreactivegroup, Y represents a linker that is null, an amine, an ether, linear orbranched C₁-C₁₀ alkyl, or a combination thereof; and R¹ and R² areindependently a photoreactive group, hydroxyl or salt thereof, cyclic,linear or branched hydrocarbon, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof; and c) illuminating thedegradable linking agent upon the support surface under conditionssuitable to activate a first photoreactive group to attach thedegradable linking agent to the support surface, wherein a secondphotoreactive species remains unbound to the support surface and is ableto revert to a latent reactive state.
 2. A support surface bearing acoating comprising a polymer layer attached to the support surface by adegradable linking agent, wherein the degradable linking agent comprisesa formula selected from:

wherein Photo¹ and Photo², independently, represent a photoreactivegroup; n is an integer between 1 and 10; and R¹-R⁴ are independentlycyclic, linear or branched, saturated or unsaturated, aromatic orheteroaromatic, a photoreactive group, hydroxyl or salt thereof, or acombination thereof;

wherein Photo¹ and Photo², independently, represent one or morephotoreactive groups; and R¹ and R² are independently a photoreactivegroup, hydroxyl or salt thereof, or a combination thereof;

wherein Photo¹ and Photo², independently, represent one or morephotoreactive groups and R is hydroxyl or a salt thereof, or acombination thereof; and

wherein Photo¹ and Photo², independently, represent a photoreactivegroup, Y represents a linker that is null, an amine, an ether, linear orbranched C₁-C₁₀ alkyl, or a combination thereof; and R¹ and R² areindependently a photoreactive group, hydroxyl or salt thereof, cyclic,linear or branched hydrocarbon, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof; and wherein a firstphotoreactive group of the degradable linking agent, when activated inthe presence of the support surface, is able to attach the degradablelinking agent to the support surface, and a second photoreactive groupof the degradable linking agent, when activated in the presence of acoating agent, is able to attach the coating to the support surface. 3.A coated medical device comprising: a medical device and a polymericcoating, wherein the coating is attached to the medical device by adegradable linking agent, wherein the degradable linking agent comprisesa formula selected from:

wherein Photo¹ and Photo², independently, represent a photoreactivegroup; n is an integer between 1 and 10; and R¹-R⁴ are independentlycyclic, linear or branched, saturated or unsaturated, aromatic orheteroaromatic, a photoreactive group, hydroxyl or salt thereof, or acombination thereof;

wherein Photo¹ and Photo², independently, represent one or morephotoreactive groups; and R¹ and R² are independently a photoreactivegroup, hydroxyl or salt thereof, or a combination thereof;

wherein Photo¹ and Photo², independently, represent one or morephotoreactive groups and R is hydroxyl or a salt thereof, or acombination thereof; and

wherein Photo¹ and Photo², independently, represent a photoreactivegroup, Y represents a linker that is null, an amine, an ether, linear orbranched C₁-C₁₀ alkyl, or a combination thereof; and R¹ and R² areindependently a photoreactive group, hydroxyl or salt thereof, cyclic,linear or branched hydrocarbon, saturated or unsaturated, aromatic orheteroaromatic, or a combination thereof.
 4. The method of coating asupport surface of claim 1, wherein the hydroxyl or salt thereofcomprises a sodium salt, a potassium salt, a lithium salt, or acombination thereof.
 5. The support surface of claim 2, wherein thehydroxyl or salt thereof comprises a sodium salt, a potassium salt, alithium salt, or a combination thereof.
 6. The coated medical device ofclaim 3, wherein the hydroxyl or salt thereof comprises a sodium salt, apotassium salt, a lithium salt, or a combination thereof.
 7. The methodof coating a support surface of claim 1, wherein one or morephotoreactive groups comprise an aryl ketone.
 8. The support surface ofclaim 2, wherein one or more photoreactive groups comprise an arylketone.
 9. The coated medical device of claim 3, wherein one or morephotoreactive groups comprise an aryl ketone.
 10. The method of coatinga support surface of claim 1, wherein one or more photoreactive groupscomprise benzophenone.
 11. The support surface of claim 2, wherein oneor more photoreactive groups comprise benzophenone.
 12. The coatedmedical device of claim 3, wherein one or more photoreactive groupscomprise benzophenone.